Ethers

<p>1,3-Bis(methoxycarbonyl)-2-methyl-2-thiopseudourea (BMTC) is a novel anticancer agent that has been synthesized to be water soluble and also has significant cytotoxicity. BMTC is believed to exert its anticancer activity by binding to the colchicine binding site on tubulin which is involved in microtubule dynamics. The antitubulin effect of BMTC results in inhibition of cell division and growth. BMTC also inhibits cancer cell proliferation and migration. It has shown significant cytotoxicity against human prostate cancer cells and ovarian cancer cells, as well as inhibiting tumor xenografts in mice.</p>

<p>Please enquire for more information about (2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Used in treatment of nonspecific ulcerative colitis</p>

<p>Please enquire for more information about N-(4-Methoxyphenylazoformyl)-Arg-OH·HCl including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>3,4,5-Trimethoxybenzoic acid anhydride is a synthetic chemical compound that is used as a pharmaceutical intermediate. It is mainly used to prepare potent anticancer agents and potent anticancer drugs. 3,4,5-Trimethoxybenzoic acid anhydride reacts with amines in the presence of a base to form substituted amides. This reaction has been shown by crystal x-ray diffraction to be sensitive to the solvent polarity and temperature of the reaction medium. The compound can also react with chloride ion to form 3,4,5-trichlorobenzoic acid anhydride (3TCBA).</p>

2-[(4-Chloro-2-nitrophenyl)azo]-N-(2-methoxyphenyl)-3-oxobutanamide is a chelating agent that has been used as a control agent in the manufacture of dyes, plastics, and rubber. It is also used as an additive in paints, textiles, and paper. 2-[(4-Chloro-2-nitrophenyl)azo]-N-(2-methoxyphenyl)-3-oxobutanamide is nonvolatile, nonflammable, and does not produce toxic byproducts when heated. This compound has low molecular weight with a molecular formula of C12H13NO5Cl. The structure of this compound includes two hydroxy groups (OH), one aliphatic hydrocarbon group (CH3), one carboxylic acid group (COOH), and three chlorine atoms (Cl). This product is soluble in water

<p>3-Methoxyphenylboronic acid is a photophysical molecule that can be used as an analytical reagent in plant physiology and analytical chemistry. 3-Methoxyphenylboronic acid reacts reversibly with copper ions to form a complex. The binding constants of the copper complex depend on the pH of the solution, which can be altered by adding a phosphate derivative to the solution. This reaction was investigated using cross-coupling techniques and showed that the binding constants for this complex are dependent on the type of solvent used. 3-Methoxyphenylboronic acid has also been used to measure glucose levels in blood samples.</p>

<p>Methoxyacetaldehyde diethyl acetal is a viscous liquid with a low vapor pressure. This substance is stable at high temperatures and has a high resistance to chemical interactions. It is also hydrophobic in nature. Methoxyacetaldehyde diethyl acetal has been shown to interact with the aminoglycoside antibiotics, erythromycin, streptomycin, and neomycin. The interaction of this substance with these antibiotics may be due to the fact that it has proton resonances similar to those of amino acids, as well as its ability to form hydrogen bonds with the antibiotic molecules. Methoxyacetaldehyde diethyl acetal also interacts with triethyl orthoformate, which can lead to the formation of an ester bond between them.</p>

<p>5-Bromo-2-methoxyphenyl)acetic acid (BMPEA) is a hydroxylated derivative of aspartic acid. It has been shown to induce apoptotic cell death in various cell lines, including human lung cells and rat hippocampal cells. BMPEA is synthesized by the solid-phase method and is characterized by a constant structure. It can be used to treat degenerative diseases and other conditions where apoptosis is desirable, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, retinitis pigmentosa, and Duchenne muscular dystrophy.</p>

<p>Please enquire for more information about 2-Hydroxy-5-methoxybenzimidazole including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>2-Methoxyethyl acetoacetate is used as a raw material for coatings. It has been shown to be an effective calcium antagonist in the treatment of leukemia and other cancers. 2-Methoxyethyl acetoacetate has also been shown to inhibit the growth of HL-60 cells when it is incubated with these cells in the presence of hydrochloric acid, malonic acid, and quinoline derivatives. The reaction produces chlorine gas, which is toxic to cells.</p>

<p>5-Amino-2-methoxy-4-methylpyridine is a small molecule that inhibits bromodomains. Bromodomains are protein domains that bind to acetylated lysine residues on histones. 5-Amino-2-methoxy-4-methylpyridine binds to the bromodomain, preventing the acetylated lysine residues from binding with other proteins and inhibiting transcription. This drug has been shown to be effective in treating prostate cancer by interacting with the androgen receptor. 5-Amino-2-methoxy-4-methylpyridine also interacts with ATPase, which may lead to increased levels of ATP production, and has been shown to have antitumor effects in vitro.</p>

<p>Please enquire for more information about N-2-Ethoxyethyl-Val-Ala-anilide including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>2-[2-Trifluoroethoxyphenoxy]ethyl methanesulfonate is a research chemical that is commonly used in the synthesis of enantioselective compounds. It has been clinically studied for its potential use in the treatment of prostatic hyperplasia, a condition characterized by an enlargement of the prostate gland. This compound has shown promising results in inhibiting the growth of prostatic cells and reducing symptoms associated with hyperplasia. Its enantioselective properties make it an ideal candidate for targeted therapy, allowing for more precise and effective treatment options. Researchers continue to explore the potential applications of 2-[2-Trifluoroethoxyphenoxy]ethyl methanesulfonate in various fields, including medicine and pharmaceuticals.</p>

<p>2-Bromo-5-hydroxy-4-methoxybenzaldehyde is a death pathway inhibitor that has been shown to have radiosensitizing effects in vitro. It has also been found to inhibit the expression of matrix metalloproteinase (MMP) in human glioma cells and in a rat model of cerebral ischemia. This compound may be used as a potential chemotherapeutic agent for the treatment of cancer. 2-Bromo-5-hydroxy-4-methoxybenzaldehyde inhibits cell proliferation by inducing apoptosis, or programmed cell death, which may be due to its ability to suppress MMP activity.</p>

<p>4-Methoxy-3-(trifluoromethyl)benzoic acid is a useful scaffold that can be used as a building block for the synthesis of complex compounds. It has been shown to react with various reagents and is a versatile building block that can be used in organic synthesis. 4-Methoxy-3-(trifluoromethyl)benzoic acid is a high quality chemical and has been classified as speciality chemicals. This product is also known by the CAS number 213598-09-5.</p>

<p>4-Chloro-6,7-dimethoxyquinoline (4C6DMQ) is a potent inhibitor of the growth of prostate cancer cells. 4C6DMQ is an analog of chloropropyl chloride, which inhibits the growth of epidermal growth factor receptor (EGFR). The binding site for 4C6DMQ on EGFR is the same as that for chloropropyl chloride. 4C6DMQ inhibits EGFR by preventing the activation of downstream signaling cascades, leading to a decrease in cell proliferation and tumor size. The IC50 values for 4C6DMQ are approximately 10 times higher than those for chloropropyl chloride. This drug has been shown to be more potent than other inhibitors of EGFR such as erlotinib and gefitinib.</p>

<p>Please enquire for more information about (4S,5R)-3-Benzoyl-2-(4-methoxyphenyl)-4-phenyl-5-oxazolidinecarboxylic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carbolin-1-one is a β-carboline alkaloid that is structurally related to harmaline and tetrahydroharmine. It has been shown to have antidepressant activity in animals. 6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carbolin-1-one was analyzed by GC/MS and found to be present in the leaves of plants from the genus Tetraclinis. 6MHBC was also identified as a metabolite of diazepam in rat urine after administration of a single oral dose of 10 mg/kg diazepam. The observed β carboline metabolite was determined to be 6MHBC.</p>

<p>Please enquire for more information about 2-(Carboxymethyl)-4,5-dimethoxybenzoic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>